Cardiovascular and CKD-Related Healthcare Costs for Patients with Type 2 Diabetes and CKD

被引：0
|
作者：
Singh, Rakesh [1 ]
Song, Jinlin [2 ]
Faust, Elizabeth [3 ]
Du, Yuxian [1 ]
Kong, Sheldon X. [1 ]
Betts, Keith A. [2 ]
机构：
[1] Bayer Corp, Whippany, NJ USA
[2] Anal Grp Inc, Los Angeles, CA USA
[3] Anal Grp Inc, New York, NY USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO0776
引用
收藏
页码：272 / 272
页数：1
相关论文
共 50 条
  • [41] Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation
    Andersen, Kirstin
    Kesper, Marie Sophie
    Marschner, Julian A.
    Konrad, Lukas
    Ryu, Mi
    Kumar, Santhosh V. R.
    Kulkarni, Onkar P.
    Mulay, Shrikant R.
    Romoli, Simone
    Demleitner, Jana
    Schiller, Patrick
    Dietrich, Alexander
    Mueller, Susanna
    Gross, Oliver
    Ruscheweyh, Hans-Joachim
    Huson, Daniel H.
    Stecher, Baerbel
    Anders, Hans-Joachim
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (01): : 76 - 83
  • [42] SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
    Thomas, Merlin C.
    Neuen, Brendon L.
    Twigg, Stephen M.
    Cooper, Mark E.
    Badve, Sunil, V
    ENDOCRINE CONNECTIONS, 2023, 12 (08)
  • [43] Cardiovascular Events with Finerenone in CKD and Diabetes REPLY
    Pitt, Bertram
    Joseph, Amer
    Schloemer, Patrick
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (16):
  • [44] Relationships of Measured Iohexol GFR and Estimated GFR With CKD-Related Biomarkers in Children and Adolescents
    Ng, Derek K.
    Schwartz, George J.
    Warady, Bradley A.
    Furth, Susan L.
    Munoz, Alvaro
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 70 (03) : 397 - 405
  • [45] HYPOGLYCEMIA-RELATED HEALTHCARE COSTS AMONG US PATIENTS WITH TYPE 2 DIABETES
    Chung, J. K.
    Lynch, P. M.
    Sierra, J. A.
    Gill, M. S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A157 - A157
  • [46] Commentary on Lessons from CKD-Related Genetic Association Studies-Moving Forward
    Kestenbaum, Bryan
    Seliger, Stephen L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (01): : 153 - 154
  • [47] The Relationship of miR-21-5p and PPARα in CKD-Related NAFLD and Dyslipidemia
    Nasci, Victoria L.
    Miller, Sophie
    Chuppa, Sandra
    Kriegel, Alison J.
    FASEB JOURNAL, 2017, 31
  • [48] Effects of Dapagliflozin on Anemia in Patients With CKD With or Without Type 2 Diabetes: A Pre-Specified Analysis of the DAPA-CKD Trial
    Heerspink, Hiddo J. L.
    Koshino, Akihiko
    Schechter, Meir
    Vart, Priya
    Jongs, Niels
    Chertow, Glenn
    Toto, Robert D.
    Rossing, Peter
    Correa-Rotter, Ricardo
    McMurray, John
    Langkilde, Anna Maria
    Wheeler, David C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 43 - 43
  • [49] Serum Uric Acid and Risk of CKD in Type 2 Diabetes
    De Cosmo, Salvatore
    Viazzi, Francesca
    Pacilli, Antonio
    Giorda, Carlo
    Ceriello, Antonio
    Gentile, Sandro
    Russo, Giuseppina
    Rossi, Maria C.
    Nicolucci, Antonio
    Guida, Pietro
    Feig, Daniel
    Johnson, Richard J.
    Pontremoli, Roberto
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (11): : 1921 - 1929
  • [50] Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
    Pergola, Pablo E.
    Raskin, Philip
    Toto, Robert D.
    Meyer, Colin J.
    Huff, J. Warren
    Grossman, Eric B.
    Krauth, Melissa
    Ruiz, Stacey
    Audhya, Paul
    Christ-Schmidt, Heidi
    Wittes, Janet
    Warnock, David G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (04): : 327 - 336
12345